SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-026624
Filing Date
2019-05-15
Accepted
2019-05-15 16:45:16
Documents
3
Period of Report
2019-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv521520_8k.htm 8-K 18088
2 EXHIBIT 99.1 tv521520_ex99-1.htm EX-99.1 87439
3 GRAPHIC image_001.gif GRAPHIC 2972
  Complete submission text file 0001144204-19-026624.txt   110811
Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37759 | Film No.: 19829099
SIC: 2836 Biological Products, (No Diagnostic Substances)